4-Aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators
作者:Hui Xiong、Todd A. Brugel、Michael Balestra、Dean G. Brown、Kelly A. Brush、Caprice Hightower、Lindsay Hinkley、Valerie Hoesch、James Kang、Gerard M. Koether、John P. McCauley、Francis M. McLaren、Laura M. Panko、Thomas R. Simpson、Reed W. Smith、James M. Woods、Becky Brockel、Vijay Chhajlani、Reto A. Gadient、Nathan Spear、Linda A. Sygowski、Minli Zhang、Jalaj Arora、Nathalie Breysse、Julie M. Wilson、Methvin Isaac、Abdelmalik Slassi、Megan M. King
DOI:10.1016/j.bmcl.2010.10.036
日期:2010.12
Positive allosteric modulation of metabotropic glutamate receptor 5 (mGluR5) is regarded as a potential novel treatment for schizophrenic patients. Herein we report the synthesis and SAR of 4-aryl piperazine and piperidine amides as potent mGluR5 positive allosteric modulators (PAMs). Several analogs have excellent activity and desired drug-like properties. Compound 2b was further characterized as a PAM using several in vitro experiments, and produced robust activity in several preclinical animal models. (C) 2010 Elsevier Ltd. All rights reserved.